• Industries
    • Chemicals
    • Cosmetic & Consumer Products
    • Pharmaceuticals & Medical Devices
    • Biocides
  • Services
    • Chemical and Product Safety
    • Regulatory Strategy and Compliance
    • QSAR Modelling
    • New Approach Methodologies
    • Endocrine disruption
    • Product Stewardship
    • Environmental Risk Assessment of Medicinal Products
  • Team
    • Team
    • Collaborations
  • Insights
    • Insights
    • Cases
    • Publications
  • Careers
  • Contact
  • Industries
    • Chemicals
    • Cosmetic & Consumer Products
    • Pharmaceuticals & Medical Devices
    • Biocides
  • Services
    • Chemical and Product Safety
    • Regulatory Strategy and Compliance
    • QSAR Modelling
    • New Approach Methodologies
    • Endocrine disruption
    • Product Stewardship
    • Environmental Risk Assessment of Medicinal Products
  • Team
    • Team
    • Collaborations
  • Insights
    • Insights
    • Cases
    • Publications
  • Careers
  • Contact
  • You are here:
  • Home
  • Insights
  • Cases
  • Feasibility screening of new molecules to be used in cosmetic applications

Feasibility screening of new molecules to be used in cosmetic applications

ToxMinds supports a large, multinational cosmetic product manufacturer in prioritising new molecules for use in cosmetic applications from a consumer safety point of view.

Over a number of years, we have been working closely with a multinational cosmetic product manufacturer in the context of qualifying upstream R&D molecules for use in their cosmetic product lines from a consumer safety point of view. This work is specifically challenging as the EU Cosmetics Regulation does not permit the use of any in vivo data for safety assessment purposes that have been generated after March 2013. Moreover, non-animal methodologies to address systemic toxicity endpoints following repeated exposure are still scarce. Considering that exposure-based waivers or TTC-type of approaches rarely help support anticipated in-use concentrations, our client particularly valued our innovative thinking and use of new risk assessment methodologies in the process. Clearly, we do not always find ways to support the molecules under consideration, but quite often we do. Our optimised analogue identification methodologies paired with our proposals for testing strategies to tie source and target substances closer strengthen the read-across cases significantly.

More cases
  • Inhalation exposure and risk assessment associated with the release of VOC, SVOC and particulates from scented candles

  • Identification of hazards associated with non-intentionally added substances in a food contact polymer

  • Evaluation of skin sensitisation potential of a class of functionalised chemicals on the basis of in silico, in vitro and in vivo data

  • Identification of safe exposure levels of ingredients used in cosmetic and consumer products

Relevant services and sectors
  • Chemical and Product Safety

  • Cosmetic & Consumer Products

Evaluation of skin sensitisation potential of a class of functionalised chemicals on the basis of in silico, in vitro and in vivo data

Previous thumb

Human health risk assessment of a biocidal product line for due diligence purposes

Next thumb
Scroll

 

ToxMinds are specialised in ensuring product safety and compliance.

We are passionate about toxicology and how emerging scientific developments can be utilised to support our customers in bringing safe, regulatory compliant and sustainable products to the marketplace.

 

 

 

 

Belgium
ToxMinds BV
Avenue de Tervueren 188A, bte 12
B-1150 Brussels Belgium

VAT BE 0877.628.383

Tel: +32 (0)2 762 9145
Email: contact us

 

 

 

 

India
ToxMinds India Consulting Pvt. Ltd.
Unit 305, 3rd Floor, Brigade IRV Centre, Whitefield, Bangalore-560066, India

 

Tel: +91 804 204 19 20
Email: contact us

 

 

 

 

 

LinkedIN
Copyright and disclaimer | Data privacy
  • Home
  • Industries
  • Services
  • Team
  • Insights
  • Careers
  • Contact
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok